The Effect of Propofol versus Inhalation Anesthetics on Survival after Oncological Surgery

Laura Jansen, Bente F. H. Dubois, Markus W. Hollmann

Research output: Contribution to journalReview articleAcademicpeer-review

6 Citations (Scopus)

Abstract

Every year, 19.3 million patients worldwide are diagnosed with cancer. Surgical resection represents a major therapeutical option and the vast majority of these patients receive anesthesia. However, despite surgical resection, almost one third of these patients develop local recurrence or distant metastases. Perioperative factors, such as surgical stress and anesthesia technique, have been suggested to play a role to a greater or lesser extent in the development of recurrences, but oncology encompasses a complicated tumor biology of which much is still unknown. The effect of total intravenous anesthesia (TIVA) or volatile anesthesia (VA) on survival after oncological surgery has become a popular topic in recent years. Multiple studies conclude in favor of propofol. Despite the a priori probability that relevant differences in postoperative outcomes are due to the anesthesia technique employed, TIVA or VA, is extremely small. The existing literature includes mainly hypothesis-forming retrospective studies and small randomized trials with many methodological limitations. To date, it is unlikely that use of TIVA or VA affect cancer-free survival days to a clinically relevant extent. This review addresses all relevant studies in the field and provides a substantiated different view on this deeply controversial research topic.
Original languageEnglish
Article number6741
JournalJournal of clinical medicine
Volume11
Issue number22
DOIs
Publication statusPublished - 1 Nov 2022

Keywords

  • TIVA
  • anesthesia
  • cancer-free survival
  • oncology
  • sevoflurane
  • volatile anesthetics

Cite this